Fri-19-12-2014, 16:53 PM
This study looked at back pain in patients with psoriasis, it concludes that there is a higher chance of lower back pain in people with psoriasis.
Source: onlinelibrary.wiley.com
Funded by
Quote:
Objective
Psoriasis is a chronic inflammatory disorder affecting 3% of the population. The objective of our study was to provide prevalence estimates for inflammatory back pain (IBP) and spondyloarthritis (SpA) in those subjects with psoriasis using 2009-2010 NHANES data.
Methods
In the NHANES 2009-2010 sample set, 6,684 persons between 20-69 years of age were screened for participation and 5,103 answered questions regarding onset of back pain, location of pain and functional limitations. Dataset assembly and statistical analysis were performed using SASTM and SUDAAN™. Standard errors were estimated by Taylor series linearization. The equality of the prevalence estimates for selected variables were tested (univariately) at the α=0.05 level using a 2-sided Student's t statistic with appropriate degrees of freedom.
Results
148 persons had self-reported medically diagnosed psoriasis. The psoriasis group, versus the non-psoriasis group, had a significantly higher prevalence of axial pain using the 3-month duration criterion (31.1% vs. 18.9%; p=0.04) and alternating buttock pain (7.2% vs. 2.4%; p=0.03) and met IBP criteria – Berlin 7b and 8a – more frequently (p=0.04, 0.02 respectively). The prevalence of SpA was significantly higher in the psoriasis group versus the non-psoriasis group when using Amor or ESSG criteria (14.3% vs. 1.5%; p<0.001). Sudden-onset of axial pain was significantly higher in the psoriasis group (23.3% vs. 13.0%; p=0.01).
Conclusion
There is a higher prevalence of lower axial pain, IBP, SpA, and alternating buttock pain associated with a prior diagnosis of psoriasis. This data may influence the way psoriasis patients are approached in primary care and speciality clinics.
Source: onlinelibrary.wiley.com
Funded by
- National Center for Health Statistics
- Centers for Disease Control and Prevention
- CTSI. Grant Numbers: UL1RR033176, PO1-AR052915